Talk:Posterior reversible encephalopathy syndrome

MRIs
Most of the article consisted of an MRI dataset. I'm not sure if there is any point in showing all the images. I'm moving it here for the time being. JFW | T@lk  20:39, 13 April 2009 (UTC)

Expanding
I've picked some recent sources that would be useful for further expansion. The Garg paper and the Pula paper are fairly good, but for the neuroradiological discussions I think we should also cite these (both by Bartynski): and, and think about touching on  (recent large case series). JFW | T@lk  20:52, 13 April 2009 (UTC)

Medications
added the following list of medicines associated with PRES, but omitted a source. Apart from the fact that we should be avoiding bullet-point lists, there was no source and some are implausible (like dexamethasone).


 * Bevacizumab
 * Cisplatin
 * Cyclosporin A
 * Cytarabine
 * Dexamethasone
 * Gemcitabine
 * Interferon alpha
 * Methotrexate
 * Rituximab
 * Sorafenib
 * Tacrolimus

A source would resolve this issue. JFW &#124; T@lk  09:01, 24 May 2013 (UTC)


 * , here is the source I used for that information:


 * Not a great source, I'm affraid. This table is from a secondary source. Should we use that instead? JFW &#124; T@lk  20:17, 24 June 2013 (UTC)

Lancet Neurol review
10.1016/S1474-4422(15)00111-8 JFW &#124; T@lk  18:25, 12 January 2016 (UTC)


 * Histopathology: 10.1093/jnen/nlx112 JFW &#124; T@lk  15:39, 6 May 2020 (UTC)


 * 10.1016/j.jns.2019.07.018 focuses on imaging. JFW &#124; T@lk  15:39, 6 May 2020 (UTC)


 * 10.1097/WCO.0000000000000640 - general review. JFW &#124; T@lk  15:39, 6 May 2020 (UTC)

Additional source
10.1136/practneurol-2021-003194 JFW &#124; T@lk  09:05, 29 May 2023 (UTC)